Azenta (AZTA) Total Current Liabilities (2010 - 2026)
Azenta (AZTA) posted quarterly Total Current Liabilities of $257.2 million for Q1 2026, up 16.35% year-over-year from $221.0 million in Q1 2025, and down 3.75% quarter-over-quarter from $267.2 million in Q4 2025.
Azenta (AZTA) Total Current Liabilities (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Total Current Liabilities for 17 consecutive years, with $257.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 16.35% year-over-year to $257.2 million; the TTM figure through Mar 2026 stood at $257.2 million (up 16.35% YoY), while the FY2025 annual figure was $267.2 million, changed N/A from the prior year.
- Total Current Liabilities eased to $257.2 million in Q1 2026 per AZTA's latest filing, from $267.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $618.0 million in Q1 2022 and bottomed at $194.9 million in Q2 2022.
- Historically, Total Current Liabilities has averaged $247.0 million across 5 years, with a median of $221.0 million in 2025.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 132.63% — and 2023, when it tumbled 65.59%.
- Azenta's Total Current Liabilities stood at $249.0 million in 2022, then dropped by 5.38% to $235.6 million in 2023, then dropped by 14.05% to $202.5 million in 2024, then soared by 31.94% to $267.2 million in 2025, then fell by 3.75% to $257.2 million in 2026.
- Business Quant data shows AZTA's Total Current Liabilities at $257.2 million in Q1 2026, $267.2 million in Q4 2025, and $237.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.25 Bn | 129.03 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.47 Bn | 51.61 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.69 Bn | 34.34 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.67 Bn | 32.20 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.17 Bn | 26.49 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.06 Bn | 24.62 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.36 Bn | 14.95 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Azenta | 1.68 Bn | 1.36 Bn | 198.10 Mn | 272.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 272.57 Mn |
| Mar 31, 2026 | 257.19 Mn |
| Dec 31, 2025 | 267.21 Mn |
| Sep 30, 2025 | 237.67 Mn |
| Jun 30, 2025 | 246.17 Mn |
| Mar 31, 2025 | 221.05 Mn |
| Dec 31, 2024 | 202.52 Mn |
| Sep 30, 2024 | 206.09 Mn |
| Jun 30, 2024 | 202.57 Mn |
| Mar 31, 2024 | 203.00 Mn |
| Dec 31, 2023 | 235.62 Mn |
| Sep 30, 2023 | 210.93 Mn |
| Jun 30, 2023 | 203.63 Mn |
| Mar 31, 2023 | 212.64 Mn |
| Dec 31, 2022 | 249.03 Mn |
| Sep 30, 2022 | 230.55 Mn |
| Jun 30, 2022 | 194.93 Mn |
| Mar 31, 2022 | 617.96 Mn |
| Dec 31, 2021 | 341.80 Mn |
| Sep 30, 2021 | 345.09 Mn |